Respiratory disease is the 3rd most common cause of death worldwide, according to the World Health Organization. Over 40 million people in the US already have a Chronic Respiratory Disease (CRD). Additionally, over 300 million Americans (9 out of 10 people) who do not want to contract an irreversible CRD have limited access to early detection systems that can identify anomalous declines in respiratory function.
Over 22,000 times a day, the human body exhales respiratory gas containing a robust and actionable dataset of the body’s overall CRD risks from its current environment. This data, unfortunately, is not routinely collected or analyzed for its CRD assessment value.
Healthmetryx provides organizations with proprietary breath data collection and AI-enabled data analysis tools to support population health, clinical and workplace wellness research. Our data license and origination offerings equip organizations with the Real-World Data found in exhaled breath—allowing them to make better health research decisions. Our offerings also help our customers assess:
-
Early warning signs that could be correlated to the exacerbation of a pre-existing CRD.
-
The early onset of a potentially new chronic respiratory condition.
-
To assess the risks of an environment to an identified population’s respiratory health.
Partners and Customers
Contact
Montreal:
4388 Rue Saint-Denis
Suite 200 #706
Montreal, Quebec H2J 2L1, CA
Boston:
867 Boylston Street
5th Floor #1939
Boston, MA 02116
855-726-8322